Egide S.A.
Egide S.A. Fundamental Analysis
Egide S.A. (GID.PA) shows weak financial fundamentals with a PE ratio of 41.28, profit margin of 0.62%, and ROE of 1.82%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 24.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze GID.PA's fundamental strength across five key dimensions:
Efficiency Score
WeakGID.PA struggles to generate sufficient returns from assets.
Valuation Score
ModerateGID.PA shows balanced valuation metrics.
Growth Score
ModerateGID.PA shows steady but slowing expansion.
Financial Health Score
ExcellentGID.PA maintains a strong and stable balance sheet.
Profitability Score
WeakGID.PA struggles to sustain strong margins.
Key Financial Metrics
Is GID.PA Expensive or Cheap?
P/E Ratio
GID.PA trades at 41.28 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, GID.PA's PEG of 0.41 indicates potential undervaluation.
Price to Book
The market values Egide S.A. at 0.72 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -3.94 times EBITDA. This is generally considered low.
How Well Does GID.PA Make Money?
Net Profit Margin
For every $100 in sales, Egide S.A. keeps $0.62 as profit after all expenses.
Operating Margin
Core operations generate 2.50 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $1.82 in profit for every $100 of shareholder equity.
ROA
Egide S.A. generates $0.71 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $-0.39 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
41.28
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.41
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.72
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.86
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.29
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.02
vs 25 benchmark
ROA
Return on assets percentage
0.007
vs 25 benchmark
ROCE
Return on capital employed
0.05
vs 25 benchmark
How GID.PA Stacks Against Its Sector Peers
| Metric | GID.PA Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 41.28 | 33.94 | Worse (Expensive) |
| ROE | 1.82% | 1002.00% | Weak |
| Net Margin | 0.62% | -48794.00% (disorted) | Weak |
| Debt/Equity | 0.86 | 0.44 | Weak (High Leverage) |
| Current Ratio | 1.29 | 5.74 | Neutral |
| ROA | 0.71% | -288341.00% (disorted) | Weak |
GID.PA outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Egide S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Growth, Innovation, High Beta
EPS CAGR
N/A
Industry Style: Growth, Innovation, High Beta
FCF CAGR
N/A
Industry Style: Growth, Innovation, High Beta